PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Nov-2019 MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis B3C newswire
21-Nov-2019 MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis B3C newswire
21-Nov-2019 MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis B3C newswire
21-Nov-2019 curasan stabilizes portfolio business in the third quarter and intensifies partner search curasan AG
21-Nov-2019 Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main (news with additional features) Expedeon AG
21-Nov-2019 Sales growth in core markets further increases margins for Vita 34 Vita 34 AG
21-Nov-2019 Asklepios Kliniken: Revenue growth in first nine months of 2019 Asklepios Kliniken
21-Nov-2019 aap Implantate AG to present at German Equity Forum 2019 aap Implantate AG
21-Nov-2019 Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish Third Quarter 2019 Results on November 28, 2019 Vivoryon Therapeutics AG
21-Nov-2019 Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park Ascentage Pharma
20-Nov-2019 Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure (news with additional features) MorphoSys AG
20-Nov-2019 New Research Demonstrates Second Direct Link Between Inflammasome Activation and Alzheimer's Disease IFM Therapeutics, LLC
20-Nov-2019 Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement Heidelberg Pharma AG
20-Nov-2019 PAION ANNOUNCES SUBMISSION OF THE MARKETING AUTHORIZATION APPLICATION FOR REMIMAZOLAM IN PROCEDURAL SEDATION TO THE EUROPEAN MEDICINES AGENCY PAION AG
20-Nov-2019 Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies Zelluna Immunotherapy
20-Nov-2019 SANGAMO ANNOUNCES UK AUTHORIZATION OF A PHASE 1/2 CLINICAL TRIAL EVALUATING THE CAR-TREG CELL THERAPY TX200 FOR KIDNEY TRANSPLANTATION SANGAMO
20-Nov-2019 First Cryoballoon Ablation Procedures Performed Using the VersaCross® Transseptal Solution Baylis Medical Company Inc.
20-Nov-2019 Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications Excelra Knowledge Solutions Pvt Ltd
20-Nov-2019 Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress IDEAYA Biosciences, Inc.
20-Nov-2019 First Cryoballoon Ablation Procedures Performed Using the VersaCross® Transseptal Solution Baylis Medical Company Inc.